New Head-to-Head Data Show TALTZ® (ixekizumab) Superiority versus TREMFYA® (guselkumab) in People with Moderate to Severe Plaque Psoriasis

Amy Giles
Increasing Engagement

Daniel Sontupe
Market Access

Pat Purcell
Meeting Engagement

Suma Ramadas, PhD
Medical Affairs

Anil Bhaskar
Unified Customer Experience

Frank Burrell
Scientific Storytelling

Matthew Durham
Omnidynamic Marketing

Liz Kane
Impactful Strategy

Brenda Snow
Authentic Patient Voice

Bud Bilanich
Success Coach

Mike Viscel
Increasing Engagement

David Linetsky
Patient Activation

Stacey Gandler
Brand Nourishment

Frank X. Powers
Healthcare Challenger Brands

Laura Blair
Medication Adherence

Matt Turner
Patient Affordability

Paul Theisen
Patient Acquisition

Thomas Shea
Programmatic Marketing